Elligo adds AI-driven clinical research tech to speed trials

Austin, Texas –(Business Wire)–Elligo Health Research®the largest healthcare support research organization, launched dataartificial intelligence Connect, a new data and technology platform that will enable rapid, data-driven clinical research. A scalable end-to-end data platform, Dataartificial intelligence Connect improves efficiency across the clinical research workflow—reducing human error and quickly ingesting patient data to accelerate clinical trials.

“The application of AI methods to healthcare and clinical research data is moving from a moonshot approach to more practical applications,” said Dr. Michael Ibara, Chief Data Officer at Elligo. “An example of this approach is the process of obtaining a patient’s medical records, which involves manual, non-scalable activities such as obtaining accurate information about a patient’s provider, requiring websites to track records, and having humans review hundreds of pages of medical documents. Recordings are categorized. The judicious and intelligent application of natural language processing (NLP), machine learning (ML) and other artificial intelligence methods increases speed, accuracy and quality while reducing the burden on sites and patients.”

By bringing together data, processes and clinical expertise, Elligo has created the industry’s first AI-driven platform that acquires, processes, analyzes and distributes patient real-world data (RWD)—meaning end-to-end problem solving Solutions Clinical trials challenge directly rather than add technology. Customizable, reusable platforms include:

  • RWD repository for electronic health records (EHR) and clinical data storage, integrating EHR, clinical trial and patient data for analytics, AI and research.

  • A complete medical records retrieval and analysis solution that transforms data into searchable, actionable insights and individual patient journey information in minutes through the right use of NLP, ML and clinical expertise.

  • A data-driven protocol development service that tests designs in the real world.

For more information on how AI-driven technologies can optimize clinical data management and accelerate clinical trials through healthcare, visit https://www.elligohealthresearch.com/for-sponsors/.

About Elligo Health Research®

Elligo Health Research accelerates clinical trials through healthcare, accessing over 150 million known patients and their HIPAA-compliant healthcare data, our IntElligo® Research Stack technology and our patientschoose Identify and engage models. Combined with the largest known patient access network, Elligo’s site solutions enable healthcare practice and research sites to participate in clinical trials. By adaptively engaging prominent patients and physicians, we accelerate the development of new drugs, biotechs, medical devices and diagnostics.

Source link